US Patent 11883408 Reboxetine to treat narcolepsy
Patent 11883408 was granted and assigned to axsome therapeutics, inc. on January, 2024 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11883408 Reboxetine to treat narcolepsy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
